Growth Metrics

Haemonetics (HAE) Cash from Financing Activities (2016 - 2025)

Haemonetics has reported Cash from Financing Activities over the past 17 years, most recently at $2.0 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 47.32% year-over-year to $2.0 million; the TTM value through Dec 2025 reached -$228.4 million, down 216.08%, while the annual FY2025 figure was $108.8 million, 185.18% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $2.0 million at Haemonetics, up from -$76.6 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $432.8 million in Q2 2021 and troughed at -$151.4 million in Q1 2025.
  • A 5-year average of $19.3 million and a median of -$2.9 million in 2021 define the central range for Cash from Financing Activities.
  • On a YoY basis, Cash from Financing Activities climbed as much as 55901.34% in 2024 and fell as far as 3861.45% in 2024.
  • Year by year, Cash from Financing Activities stood at -$3.3 million in 2021, then plummeted by 1398.64% to -$49.7 million in 2022, then skyrocketed by 320.27% to $109.4 million in 2023, then crashed by 98.74% to $1.4 million in 2024, then soared by 47.32% to $2.0 million in 2025.
  • Business Quant data shows Cash from Financing Activities for HAE at $2.0 million in Q4 2025, -$76.6 million in Q3 2025, and -$2.4 million in Q2 2025.